| Tag | Content |
|---|
EnhancerAtlas ID | HS197-03214 |
Organism | Homo sapiens |
Tissue/cell | ZR75-30 |
Coordinate | chr10:115547810-115549860 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr10:115549833-115549845 | AAACAAACAAAC | - | 6.32 | | NFE2L1 | MA0089.2 | chr10:115548596-115548611 | GAATGACTCAGCGTT | + | 6.21 | | Nr2f6(var.2) | MA0728.1 | chr10:115548074-115548089 | GAGGTCAGGAGTTCA | + | 6.22 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH10I113788 | chr10 | 115548188 | 115549279 |
|
Enhancer Sequence | TAATTAGAGG CAGTGTAAAA TCACTCTCCA AGAAAAATCA GAGGACAATG AACTATCAAA 60
CTACATGGTG ATAGCAGGGT TCAGAAAGGA AGGAGATCGT GATGGAACAG AATGCCAACC 120
ATGACTAACA TGCAGAGAGT GCCTTCTATC TGCCGGGCAA TATTCAAACA CTCTACTGAC 180
TCCTATAAAA GCCCTGTGGG CCAGGTGCAG TGGCTCACAT CTGTAATCCC AGCACTTTGG 240
GAGGCCGAGG CAGGTGGATC ACTTGAGGTC AGGAGTTCAA GACCAGCTTG GCCAATATGG 300
AGAAACCCTG TCTCTACAAA AATACAAAAA TAAGCTGGGC GTCGTGGCGG GCATCTGTAA 360
TCCCACCTGC TCGGGAGTCT GAGGCAGGAG AATCGCTTGA GCTTGAACTC GGGAGGTGGA 420
GGTTGCGGTG AGCTGAGATA CTGCCACTAC GCTCCAGCCT GGGTGAGAGA GCGAGACCCT 480
CTCTCAAAAC AAAAACAAAA CAAAAAACAG CCCTGCGAGA CCAGGACTCT TATTGTCCCC 540
GGGTTTCGGA TGGGGAGACA AAGCACAGAG AAGATACATC GCTTGCTCAG GGCTATGGCT 600
AGTACCAGAC AGAGCCAGAA CTCAGACCAG AAAGACTGGC TTTGGAGACC ACAGGCGTCC 660
TGAAAGAGGA GCTGAAACTG AGCTCTGGAA GAGAATAATC CAGCAAGGGA CGGCGGTGCA 720
GACAGGATCA GACATGGAGC TCACTTTCCA AAAGTAAAAA CAGGGAACAT GTTGGAATGA 780
CTCATAGAAT GACTCAGCGT TTTTATACAT CTCTCATTTC AGTAACACGC ATTCATCTTT 840
GGGCCTATTG CCCAGAAGAA TCACAAAAGT GGTTCCTTTT GTGGTTCCGG GAGCCAGGGG 900
AATTCTGTGG CAGCTTCTGT TATGACTAGT AAACGCGTTT CATAACCCTC CTTTGAGTTG 960
GCCATCTGGC TCTATATTAT ACTCAAGTTA ATACAAAACT AATGCATACT TCTAGTGACA 1020
AAGGCATTAG GCTAGTCCTC TGGACAGGAG ATAATAAAGA ATCCTTGGCT TTGTAGACCT 1080
CGTCATCAAG TGAAGGTAAT AAAAACATAC ACATAGATAC CTACAAGGCA AATATGATTA 1140
TCCTAAATCC TTTGTTAAAG TCACAACTCA ATGTTACAAA CACAAAAGGC TTAAAGACTA 1200
ATTCTATCTA GTTGGTTTGG AAAAAGCTTC AAGGGAGGGA TATATTTGGG GTGCAGAGAT 1260
GTAGTGGGAG GGATTTCATG TCTTGAAGAA TGAATAGGAT TCACTTAATA TTCTAGAACA 1320
GGTCAAACCC CCAGTGCACA GCCACCAGAA TGTAACTGGA GGGCCAAAGA AGTTCTCAAG 1380
CGTCCTGTAG AACTCCCTAA TCCCTGTCGG CTGTCACTGT CATCACTTTT CCAGCATCTT 1440
CTGGGTTCAG GGGACTGTCA GGCACTGGTG ATATTAACAG GAATAAAATA TGTTCCCTCA 1500
GGGAGGTGAT AGCCTAATTA AGGATACAGG TGTGAAAATT GTTTAGGGGT AAAAAGTTCC 1560
CTTGTAGAAT GAAAATATAT GTCCACACAT AAACGTGTGT ATGAATGTTC ATAGTAGCGT 1620
TATTCATAAC AGCCAAAAAG TGAAAATGTC CATTAACTGA GGAATAGATA AATAAAATGT 1680
GATATATTCA TGGAATAAAT AATATGGGAT ATTATTTAGT CATAAAAAAG AGGCCGGGCA 1740
TGGTGGCTCA TGCCTGTAAT CCCAGCATTT TGGGAGGCCA AGGCGGATGC ATCTCCTGAG 1800
CTCAGGAGTT TGAGACAAGC CTGGGCAATA TGGCAAAATC CCGTCTCTAT CAAAAATATA 1860
AAAAATTAGC TGGACATGGT GGCACACACC TGTGGTCCCA GCTACTCAGG AGGCTGAGGT 1920
GGAAGGATCA CTTGAGTCTT GGGAGGCGGA GGTTACAGTG AGCCGAGATA GTGCCACTGC 1980
ATTCCGAACT GAGTGACAGA GTGAGACTCT GTCTCAAGAA AAAAAACAAA CAAACAAGAA 2040
TGAAGTACTG 2050
|
